Trends in Indonesia Clinical Laboratory Market REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Indonesia clinical laboratory market segment (by type of clinical laboratory, by type of private independent laboratory, by type of customer, by payer, by type of test and by region), competitive landscape of major players in Indonesia clinical laboratory market, and covering company profile of major clinical labs including Prodia, Kimia Farma Diagnostika, Pramita, Cito, BioMedika and Parahita. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions. The healthcare market in Indonesia was majorly impacted by the implementation of JKN (Indonesian National Health Insurance) as the demand for affordable/primary healthcare services, laboratory services, and generic medicines increased. The private independent clinical laboratory market is dominated by organized laboratory chains. Prodia is the market leader in Indonesia Clinical Laboratory Market supported by the largest labs network and experienced management team. Indonesia Healthcare market will be facilitated by the rising number of healthcare providers coupled with elevating prevalence of chronic diseases such as diabetes, HIV, Tuberculosis and others. More than 35,000 new beds are likely to be added in Indonesia by 2020. The clinical laboratory market is expected to increase 1.5 times by 2022 supported by higher growth in esoteric tests segment. The esoteric tests segment is expected to register a high growth during this period. The standardization of the Coordination of Benefits (CoB) agreement between private insurers and JKN will create opportunities for private independent laboratories to collaboration with private hospitals resulting in increase in external referrals. Private hospitals without facilities to perform specialized or esoteric tests will be able to refer out these tests to private independent laboratories for those patients who require these tests and are covered through the CoB scheme. The major private independent laboratories chains are expected to undergo geographic expansion beyond key cities into underdeveloped areas. This will further lead to increase in market share in the overall Indonesia clinical laboratory market. For instance Prodia plans to establish up to 33 new clinical laboratories by 2021. Further, the industry will witness a rising trend towards precision medicine also known as personalized medicine. Growth in the availability of testing equipment that can be operated locally and that does not require free-standing clinical laboratories and advancements in self-testing kits that can be operated by customers themselves can result in a decrease in the volume of tests at laboratories. Rising awareness of preventive healthcare supported by growing disposable income coupled with elevating prevalence of chronic and lifestyle diseases will lead to an increase in number of walk-in patients which will propel Indonesia clinical laboratory market revenue in future. Ken Research in its latest study, “Indonesia Clinical Laboratory Market Outlook to 2022 – By Type (Public Clinical Lab, Private Hospital Labs and Private Independent Labs), By Type of Test (Routine, Non Laboratory and Esoteric)”, suggests that clinical laboratory market is expected to reach USD 3.2 billion by 2022 growing at a CAGR of 11.5%. For More Information on the research report, refer to below link: https://www.kenresearch.com/healthcare/diagnostics/indonesia-clinical-lab-market/143543-91.html Related Reports by Ken Research: – Saudi Arabia Healthcare Market Outlook to 2019 – Rising Lifestyle Diseases And Government Investment To Spur Future Growth UAE Healthcare Market Outlook to 2020 – Rising Medical Tourism And High Prevalence Of Diabetes To Foster Future Growth Qatar Healthcare Market to 2021 – High Prevalence Of Diabetes And Rising Healthcare Infrastructure To Foster Future Growth Contact Us: Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Tags: Budget Allocation on Healthcare Indonesia, Clinical Laboratory Market Future Trends Indonesia, Clinical Laboratory Market Size Indonesia, Government Regulations in Indonesia Clinical Laboratory market, Healthcare Market Size Indonesia, Healthcare Spending Indonesia, Indonesia Clinical Laboratory value Chain, Indonesia Healthcare Market Future, Issues & Challenges in Indonesia Clinical Laboratory Market, Major Companies Clinical Laboratory Market Indonesia, Major Laboratory Chains in Indonesia, Major Type of Clinical Laboratory Tests Indonesia, Market Share of Major Players in Indonesia Clinical Laboratory Market, Number of Healthcare Centers in Indonesia, Number of Lab Tests in Indonesia, Number of Private Hospital Labs Indonesia, Number of Private Independent Labs Indonesia, Number of Public Clinical Labs Indonesia, Obese Population Indonesia, Prodia Competitors Indonesia, Trends in Indonesia Clinical Laboratory Market, Type of Customers in Indonesia Clinical Laboratory Market